DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 42 · July 2009 DOI: 10.1055/s-002-19289

Original Paper

129
Zhang, Y.; Lehmann, M.; Shobeiry, A.; Höfer, D.; Johannes, S.; Emrich, H. M.; Dietrich, D. E.: Effects of Quetiapine on Cognitive Functions in Schizophrenic Patients: A Preliminary Single-trial ERP Analysis
135
Suarez, D.; Haro, J. M.; Novick, D.; Perrin, E.; Ochoa, S.; Naber, D.: Reasons and Outcomes of Olanzapine Dose Adjustments in the Outpatient Treatment of Schizophrenia
141
Neuhaus, A. H.; Opgen-Rhein, C.; Urbanek, C.; Hahn, E.; Ta, T. M. T.; Seidelsohn, M.; Strathmann, S.; Kley, F.; Wieseke, N.; Sander, T.; Dettling, M.: COMT Val158Met Polymorphism is Associated with Cognitive Flexibility in a Signal Discrimination Task in Schizophrenia
145
Novick, D.; Gonzalez-Pinto, A.; Haro, J. M.; Bertsch, J.; Reed, C.; Perrin, E.; Tohen, M.: Translation of Randomised Controlled Trial Findings into Clinical Practice: Comparison of Olanzapine and Valproate in the EMBLEM Study
153
Bachmann, C. J.; Lehr, D.; Theisen, F. M.; Preiß, M.: Aripiprazole as an Adjunct to Clozapine Therapy in Adolescents with Early-onset Schizophrenia: A Retrospective Chart Review
158
Berwaerts, J.; Cleton, A.; Herben, V.; Vliet, I. van de; Chang, I.; Hoek, P. van; Eerdekens, M.: The Effects of Paroxetine on the Pharmacokinetics of Paliperidone Extended-release Tablets

Letter

164
Gade, K.; Häußinger, C.; Bandelow, B.: Atypical Anorexia in a Male Patient Accompanied by Strong Obsessive-compulsive Symptoms Successfully Treated with Naltrexone
166
Englisch, S.; Weinbrenner, A.; Inta, D.; Zink, M.: Aripiprazole for the Management of Olanzapine-induced Weight Gain